Myocarditis and pericarditis after COVID-19 vaccination: clinical guidance
Clinical guidance on myocarditis and pericarditis after COVID-19 vaccination for healthcare professionals.
Documents
Details
Clinical guidance to support the detection and management of clinical cases of myocarditis and pericarditis associated with coronavirus (COVID-19) vaccination.
Further information for healthcare professionals is available.
Updates to this page
Published 29 November 2021Last updated 9 January 2023 + show all updates
-
Updated guidance.
-
Updated myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals.
-
Added links to 2 studies and MHRA's weekly summary report.
-
First published.